EUVIMEDEUVIMED entdecken
Crossref

IL-1β Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a

Erika Jang iD, Tse Wing Winnie Ho iD, John H Brumell iD, François Lefebvre, Changsen Wang, Warren L Lee iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024

DOI: 10.1161/atvbaha.124.320940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Erika Jang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Keenan Centre for Biomedical Research, St. Michael's Hospital, Toronto, ON, Canada (E.J., T.W.W.H., C.W., W.L.L.). Hauptthemen laut MEDLINE: Transcytosis, Interleukin-1beta, Receptors, LDL, rab GTP-Binding Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In early atherosclerosis, circulating LDLs (low-density lipoproteins) traverse individual endothelial cells by an active process termed transcytosis. The CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study) treated advanced atherosclerosis using a blocking antibody for IL-1β (interleukin-1β); this significantly reduced cardiovascular events. However, whether IL-1β regulates early disease, particularly LDL transcytosis, remains unknown. METHODS: We used total internal reflection fluorescence microscopy to quantify transcytosis by human coronary artery endothelial cells exposed to IL-1β. To investigate transcytosis in vivo, we injected wild-type and knockout mice with IL-1β and LDL to visualize acute LDL deposition in the aortic arch. RESULTS: Exposure to picomolar concentrations of IL-1β induced transcytosis of LDL but not of albumin by human coronary artery endothelial cells. Surprisingly, expression of the 2 known receptors for LDL transcytosis, ALK-1 (activin receptor-like kinase-1) and SR-BI (scavenger receptor BI), was unchanged or decreased. Instead, IL-1β increased the expression of the LDLR (LDL receptor); this was unexpected because LDLR is not required for LDL transcytosis. Overexpression of LDLR had no effect on basal LDL transcytosis. However, knockdown of LDLR abrogated the effect of IL-1β on transcytosis rates while the depletion of Cav-1 (caveolin-1) did not. Since LDLR was necessary but overexpression had no effect, we reasoned that another player must be involved. Using public RNA sequencing data to curate a list of Rab (Ras-associated binding) GTPases affected by IL-1β, we identified Rab27a. Overexpression of Rab27a alone had no effect on basal transcytosis, but its knockdown prevented induction by IL-1β. This was phenocopied by depletion of the Rab27a effector JFC1 (synaptotagmin-like protein 1). In vivo, IL-1β increased LDL transcytosis in the aortic arch of wild-type but not Ldlr −/− or Rab27a-deficient mice. The JFC1 inhibitor nexinhib20 also blocked IL-1β–induced LDL accumulation in the aorta. CONCLUSIONS: IL-1β induces LDL transcytosis by a distinct pathway requiring LDLR and Rab27a; this route differs from basal transcytosis. We speculate that induction of transcytosis by IL-1β may contribute to the acceleration of early disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscytosisInterleukin-1betaReceptors, LDLrab GTP-Binding ProteinsMice, KnockoutEndothelial CellsLipoproteins, LDLCoronary VesselsSignal TransductionAnimalsHumansCells, CulturedMice, Inbred C57BLCaveolin 1Aortic DiseasesDisease Models, AnimalAorta, ThoracicAtherosclerosisMaleMice

Stichwörter der Autor:innen

albuminsatherosclerosisinterleukin-1microscopy, fluorescencetranscytosis

Substanzen

Interleukin-1betaReceptors, LDLrab GTP-Binding ProteinsLipoproteins, LDLLDLR protein, humanIL1B protein, humanCaveolin 1IL1B protein, mouseCav1 protein, mouse

Autor:innen und Institutionen

  • Keenan Centre for Biomedical Research, St. Michael's Hospital, Toronto, ON, Canada (E.J., T.W.W.H., C.W., W.L.L.).
  • Department of Laboratory Medicine and Pathobiology (E.J., T.W.W.H., W.L.L.), University of Toronto, ON, Canada.
  • Cell Biology Program, Hospital for Sick Children, Toronto, ON, Canada (J.H.B.).
  • Canadian Centre for Computational Genomics, McGill University, Montreal, QC, Canada (F.L.).
  • Department of Biochemistry (W.L.L.), University of Toronto, ON, Canada.
  • Department of Medicine and the Interdepartmental Division of Critical Care Medicine (W.L.L.), University of Toronto, ON, Canada.

ORCID-Profile: Erika Jang, Tse Wing Winnie Ho, John H Brumell, Warren L Lee

Zitieren

APA

Jang, E., Ho, T. W. W., Brumell, J. H., Lefebvre, F., Wang, C., & Lee, W. L. (2024). IL-1β Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.320940

Vancouver

Jang E, Ho TWW, Brumell JH, Lefebvre F, Wang C, Lee WL. IL-1β Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.124.320940

BibTeX
@article{Jang2024,
  author = {Jang, Erika and Ho, Tse Wing Winnie and Brumell, John H and Lefebvre, François and Wang, Changsen and Lee, Warren L},
  title = {IL-1β Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  doi = {10.1161/atvbaha.124.320940}
}
Kostenlos starten →